Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Bicaku, Elona
14  Ergebnisse:
Personensuche X
?
1

BCL2 antagonist of cell death kinases, phosphatases, and ov..:

Bansal, Nisha ; Marchion, Douglas C. ; Bicaku, Elona...
Journal of Gynecologic Oncology.  23 (2012)  1 - p. 35 , 2012
Link: https://doi.org/10.3802/..
 
?
2

The BCL2 antagonist of cell death pathway influences endome..:

Chon, Hye Sook ; Marchion, Douglas C. ; Xiong, Yin...
Gynecologic Oncology.  124 (2012)  1 - p. 119-124 , 2012
Link: https://doi.org/10.1016/..
 
?
3

Addition of a histone deacetylase inhibitor redirects tamox..:

Thomas, Scott ; Thurn, Kenneth T. ; Biçaku, Elona..
Breast Cancer Research and Treatment.  130 (2011)  2 - p. 437-447 , 2011
Link: https://doi.org/10.1007/..
 
?
4

Cyclin-dependent kinase activating kinase/Cdk7 co-localizes..:

Bicaku, Elona ; Patel, Rekha ; Acevedo-Duncan, Mildred
Tissue and Cell.  37 (2005)  1 - p. 53-58 , 2005
Link: https://doi.org/10.1016/..
 
?
5

Sequence‐specific potentiation of topoisomerase II inhibito..:

Marchion, Douglas C. ; Bicaku, Elona ; Daud, Adil I....
Journal of Cellular Biochemistry.  92 (2004)  2 - p. 223-237 , 2004
Link: https://doi.org/10.1002/..
 
?
6

BAD-mediated apoptotic pathway is associated with human can..:

STICKLES, XIAOMANG B ; MARCHION, DOUGLAS C ; BICAKU, ELONA...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
7

A novel c-Met inhibitor, MK8033, synergizes with carboplati..:

MARCHION, DOUGLAS C ; BICAKU, ELONA ; XIONG, YIN...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536335/.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
8

The O-glycan pathway is associated with in vitro sensitivit..:

ZGHEIB, NADIM BOU ; XIONG, YIN ; MARCHION, DOUGLAS C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
9

Characterizing the efficacy of fermented wheat germ extract..:

Judson, Patricia L ; Al Sawah, Entidhar D ; Marchion, Douglas C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
10

The BCL2 Antagonist of Cell Death pathway influences endome..:

Chon, Hye Sook ; Marchion, Douglas C ; Xiong, Yin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744065/.  , 2011
Link: http://www.ncbi.nlm.nih...
 
?
11

The BCL2 antagonist of cell death pathway influences endome..:

Hye Sook, Chon ; Chon, Hye Sook ; Marchion, Douglas C...
Gynecologic Oncology.  , 2011
Link: http://ufdc.ufl.edu/LS00..
 
?
12

BAD phosphorylation determines ovarian cancer chemo-sensiti..:

Marchion, Douglas C ; Cottrill, Hope M ; Xiong, Yin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186862.  , 2011
Link: http://www.ncbi.nlm.nih...
 
?
13

Addition of a histone deacetylase inhibitor redirects tamox..:

Thomas, Scott ; Thurn, Kenneth T ; Biçaku, Elona..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760725.  , 2011
Link: http://www.ncbi.nlm.nih...
 
?
14

The BCL2 antagonist of cell death pathway influences endome..:

Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA ( host institution ) ; Chon, Hye Sook ( author ) ; Marchion, Douglas C. ( author )...
Gynecologic Oncology.  , 2012
Link: https://doi.org/10.1016/..
 
1-14